FDA Extends Comment Period for Combo Products Rule

Devices & Diagnostics Letter
A A
At the request of stakeholders, the FDA has extended the comment period to Feb. 5 on a proposed rule on good manufacturing practices (GMPs) for combination products.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00